Mind Medicine (MindMed) (OTCMKTS:MMEDF) Trading Up 3.3% – What’s Next?

Mind Medicine (MindMed) Inc. (OTCMKTS:MMEDF)’s share price was up 3.3% on Monday . The stock traded as high as $7.37 and last traded at $7.30. Approximately 1,363,621 shares were traded during mid-day trading, a decline of 60% from the average daily volume of 3,376,665 shares. The stock had previously closed at $7.07.

Mind Medicine (MindMed) Stock Up 3.3%

The company has a 50-day moving average price of $6.20 and a 200 day moving average price of $6.99.

About Mind Medicine (MindMed)

Mind Medicine (MindMed) Inc, a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC.